Efficacy and safety of reduning injection combined with azithromycin in the treatment of mycoplasma pneumonia among children: A systematic review and meta-analysis

阿奇霉素 医学 荟萃分析 支原体肺炎 科克伦图书馆 内科学 科学网 中医药 随机对照试验 肺炎 抗生素 替代医学 肺炎支原体 病理 生物 微生物学
作者
Hongxia Wang,Meixiang Zhao,Shijian Liu,Xuefeng Wang
出处
期刊:Phytomedicine [Elsevier]
卷期号:106: 154402-154402 被引量:9
标识
DOI:10.1016/j.phymed.2022.154402
摘要

Reduning (RDN) injection is a well-known traditional Chinese medicine (TCM) preparation that can be used as an alternative to antibiotics with synergistic and toxicity-reducing effects. In China, RDN is widely used in the combined treatment of infectious diseases.To evaluate the clinical efficacy of RDN combined with azithromycin (AZM) for the treatment of mycoplasma pneumonia (MP) among children and to determine its safety, providing an evidence-based reference for clinical treatment.Eight databases were searched, including 4 English databases, namely, PubMed, EMBASE, the Cochrane Library, and Web of Science, and 4 Chinese databases, namely, China National Knowledge Infrastructure (CNKI), Wanfang, China Science and Technology Journal Database (CQVIP), and Sino-Med. Randomized controlled trials (RCTs) were included in which RDN was combined with AZM for the treatment of MP pediatric patients. A comprehensive search was performed from the inception of each database until April 25, 2022.A total of 20 studies covering 1628 children were included. Meta-analysis showed that the clinical effectiveness rate (RR = 1.20, 95% CI [1.15, 1.26], I2 = 0%), time elapsed until disappearance of cough (MD = -2.04, 95% CI [-2.67, -1.41], I2 = 91%), time elapsed until disappearance of lung rales (MD = -2.55, 95% CI [-3.12, -1.98], I2 = 95%), time elapsed until reduction of fever (MD = -1.93, 95% CI [-2.37, -1.49], I2 = 92%), TNF-α level after treatment (SMD = -1.17, 95% CI [-1.96, -0.39], I2 = 97%), and IL-6 levels after treatment (SMD = -2.65, 95% CI [-3.51, -1.78], I2 = 97%) of the combined treatment of MPP were superior to those of other methods, and incidence of adverse reactions (RR = 0.75, 95% CI [0.56, 1.00], I2 = 0%) showed statistically significant differences.RDN combined with AZM for the treatment of MP among children results in increased clinical efficacy with high safety.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
天天快乐应助贺岚采纳,获得10
1秒前
百里盼山发布了新的文献求助10
1秒前
fz1完成签到 ,获得积分10
2秒前
wongshanshan应助喜悦的易槐采纳,获得10
2秒前
SciGPT应助烫嘴普通话采纳,获得10
2秒前
蔚蓝绽放完成签到,获得积分10
2秒前
wanayu发布了新的文献求助10
2秒前
BGI789完成签到,获得积分10
3秒前
老jia完成签到,获得积分10
3秒前
Yang发布了新的文献求助10
3秒前
4秒前
林珠子发布了新的文献求助10
4秒前
xyawl425完成签到,获得积分10
4秒前
栗子完成签到,获得积分10
5秒前
kiki完成签到,获得积分10
5秒前
tr完成签到,获得积分20
5秒前
西松屋地铁完成签到 ,获得积分10
5秒前
依梦完成签到,获得积分10
5秒前
6秒前
6秒前
烟花应助默默的无敌采纳,获得10
6秒前
丘比特应助默默的无敌采纳,获得10
6秒前
516165165完成签到,获得积分10
7秒前
7秒前
完美世界应助疯狂的安波采纳,获得10
8秒前
8秒前
高大凌寒完成签到,获得积分10
8秒前
shangying完成签到,获得积分20
9秒前
和谐的如柏完成签到,获得积分10
9秒前
百里盼山完成签到,获得积分20
9秒前
传奇3应助朱朱采纳,获得10
9秒前
Lee完成签到,获得积分10
10秒前
10秒前
mouxq发布了新的文献求助10
10秒前
XHW发布了新的文献求助10
12秒前
111发布了新的文献求助10
12秒前
shangying发布了新的文献求助10
13秒前
美少叔叔完成签到 ,获得积分10
13秒前
13秒前
高分求助中
歯科矯正学 第7版(或第5版) 1004
Semiconductor Process Reliability in Practice 1000
Smart but Scattered: The Revolutionary Executive Skills Approach to Helping Kids Reach Their Potential (第二版) 1000
Nickel superalloy market size, share, growth, trends, and forecast 2023-2030 600
GROUP-THEORY AND POLARIZATION ALGEBRA 500
Mesopotamian divination texts : conversing with the gods : sources from the first millennium BCE 500
Days of Transition. The Parsi Death Rituals(2011) 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3235033
求助须知:如何正确求助?哪些是违规求助? 2881221
关于积分的说明 8219926
捐赠科研通 2548967
什么是DOI,文献DOI怎么找? 1378095
科研通“疑难数据库(出版商)”最低求助积分说明 648121
邀请新用户注册赠送积分活动 623590